CIK 0001773751
- Large accelerated filer
Hims & Hers Health, Inc.
Sign in to watch- Ticker
- HIMS
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-851-0195
- Business address
- 2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
- Former names
- Oaktree Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,483,933
- in 10 filings, $2.5M under 10b5-1 plans
Net −$2,483,933. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +108,334 | $2.43 | $263K | 268,549 |
| 2025-06-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +17,001 | $2.43 | $41K | 285,550 |
| 2025-06-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −17,001 | $58.61 | $996K | 268,549 |
| 2025-06-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −90,624 | $56.39 | $5.1M | 177,925 |
| 2025-06-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −17,710 | $56.92 | $1.0M | 160,215 |
| 2025-06-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −108,334 | 864,731 | ||
| 2025-06-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −17,001 | 85,009 | ||
| 2025-06-16 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −5,451 | $56.80 | $310K | 165,881 |
| 2025-06-13 | Chi Michael Chief Commercial Officer | Exercise or conversion 10b5-1 | +87,106 | 343,486 | ||
| 2025-06-13 | Chi Michael Chief Commercial Officer | Shares withheld for taxes 10b5-1 | −48,166 | $55.48 | $2.7M | 295,756 |
| 2025-06-13 | Chi Michael Chief Commercial Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −9,356 | 28,069 | ||
| 2025-06-13 | Chi Michael Chief Commercial Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −16,496 | 82,478 | ||
| 2025-06-13 | Chi Michael Chief Commercial Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −16,297 | 114,081 | ||
| 2025-06-13 | Chi Michael Chief Commercial Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −19,358 | 212,943 | ||
| 2025-06-13 | Chi Michael Chief Commercial Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −10,599 | 158,988 | ||
| 2025-06-13 | Chi Michael Chief Commercial Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −15,000 | 0 | ||
| 2025-06-13 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +164,368 | 253,679 | ||
| 2025-06-13 | Dudum Andrew Chief Executive Officer | Shares withheld for taxes 10b5-1 | −90,672 | $55.48 | $5.0M | 163,007 |
| 2025-06-13 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −35,242 | 105,726 | ||
| 2025-06-13 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −35,446 | 248,126 |
Page 30 of 37 · 739 trades